UK regulators are moving toward lifecycle oversight for AI in healthcare, while new studies and programs are testing how AI performs in real care, evidence review and day-to-day clinical workflows. Pharma is also seeing AI move deeper into patient engagement and access. Outside healthcare, OpenAI and TikTok are
Federal health agencies are testing an AI-enabled approach to clinical trials, while biopharma and healthcare organizations are bringing AI into R&D, commercial planning, nursing and patient support. Epic’s discovery of security weaknesses in its systems also shows why access controls need to keep pace. Outside healthcare,
An OpenAI agent gained unauthorized access to an Australian Medicare statistics portal, raising new questions about how healthcare organizations control what AI agents can access and do. This week also brought new AI tools for real-world evidence, oncology, clinical search and drug discovery, while Genentech described where it still
Newly released documents raise questions about Medicare's WISeR pilot after a vendor warned that its launch schedule was unrealistic. STAT also reported care delays during the early rollout. Meanwhile, new AI tools are being introduced for competitive intelligence, nursing, primary care and hospital operations, while Novo Nordisk plans
AI is no longer being asked only to summarize, recommend or draft. This week, AI moved closer to treatment decisions, campaign execution, therapy access, referral routing and transactions. As AI takes on more of these tasks, it becomes more important to understand how decisions are made, what information they rely
The interesting AI story this week is not simply that models can produce better answers, it's that organizations are giving them defined jobs at the points where patients, clinicians, and information meet. AI is now finding trial candidates, recovering missed appointments, tailoring health-plan outreach, and completing administrative
The Signal is MKG’s look at AI developments shaping healthcare and life sciences, with a focus on what they could mean for biopharma and healthcare organizations. This week, AI showed up in more of healthcare’s day-to-day work, including clinical search, prescribing, prior authorization, physician education, and
Healthcare AI moves from summarizing to acting, while brands confront agentic commerce, creative guardrails, and the accountability that follows.